Xconomy

JANUARY 29, 2020

Agenda topics include Successful Research & Development Models, What It Takes for Commercialization, and Building a Biotech Ecosystem in San Diego. Speakers include Jay Lichter, CEO of COI Pharma and Managing Director at Avalon Ventures; Ciara Kennedy, CEO of Amplyx; and Kim Kamdar, Partner at Domain Associates. $99

San Diego 79

San Diego Avalon Research Ideas 79

socalTECH

OCTOBER 18, 2012

San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. Selectable Media, which is based in New York, lets users opt into branded video advertising in exchange for free access to content on web and mobile apps. READ MORE>>.

Avalon 147

Avalon Media San Diego Advertising 147

socalTECH

DECEMBER 2, 2010

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.

Avalon 154

Avalon Invest Cloud Computing San Diego 154

socalTECH

OCTOBER 20, 2014

San Diego-based therapeutic antibody developer AnaptysBio announced this morning that it has named Marco Londei as its Chief Development Officer. AnaptysBio is backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures, Novo A/S, Numenor Ventures, WS Investments, and others. READ MORE>>.

Develop 147

Develop Development Avalon San Diego 147

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

MARCH 31, 2020

San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round.

Funding 140

Funding Avalon San Diego Platform 140

Xconomy

AUGUST 31, 2016

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological processes, has died, according to a statement from the university. He compared himself to John C.

San Diego 72

San Diego UCSD Avalon Study 72

socalTECH

JULY 28, 2020

San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. AristaMD develops telehealth software used for virtual consultations, allowing primary care physicians to consult with medical specialists virtually.

Funding 100

Funding Avalon San Diego Software Development 100

socalTECH

NOVEMBER 13, 2019

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124

Avalon San Diego Incubator Technology 124

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing.

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

SEPTEMBER 27, 2016

San Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. READ MORE>>.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

JULY 14, 2017

San Diego-based StackIQ , a developer of "bare metal" provisioning software, has been acquired by Teradata , Teradata said on Thursday. StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. Financial terms of the acquisition were not announced.

Avalon 113

Avalon Anthem San Diego Acquisition 113

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. READ MORE>>.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

JULY 17, 2014

invested in San Diego, and $66.53M invested in Orange County during the period. for San Diego-based biopharmaceuticals firm Otonomy ; and $48.0M for San Diego''s Veredezyne , which is developing biofuels and biochemicals processes. The numbers are based on data provided to the two by Thomson Reuters.

Southern California 240

Southern California El Segundo Culver City Orange County 240

socalTECH

NOVEMBER 28, 2016

San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. Doyle as its Chief Business Officer. READ MORE>>.

Avalon 100

Avalon San Diego Capital Funding 100

socalTECH

AUGUST 18, 2016

San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. and laos included Ervington Investments Limited and Alexandria Venture Investments plus Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures. Andrei Petrov, Ph.D., READ MORE>>.

Avalon 100

Avalon San Diego Invest Funding 100

socalTECH

JANUARY 9, 2014

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

DECEMBER 6, 2012

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

MARCH 5, 2013

San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. Anaptys priced its IPO on Wednesday night at $15.00 READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

JULY 14, 2014

San Diego-based Otonomy , the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Market. Otonomy said it intends to list under the symbol OTIC. READ MORE>>.

Avalon 147

Avalon San Diego Acquisition Marketing 147

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. READ MORE>>. otonomy biopharmaceuticals biotech lifescience venture capitall inner disorder disease'

Funding 138

Funding Avalon San Diego Capital 138

socalTECH

SEPTEMBER 5, 2013

San Diego-based server side caching software developer Proximal Data has inked a deal with LSI Corporation , where LSI will integrate its server-side caching technology with a PCIe flash application acceleration product. Proximal Data is venture backed by Divergent Ventures and Avalon Ventures. READ MORE>>.

Avalon 138

Avalon San Diego Software Development Software 138

socalTECH

AUGUST 13, 2014

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 The company is developing treatments for disorders of the inner ear. Otonomy was backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, and Rivervest Venture Partners. READ MORE>>.

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

JULY 22, 2016

San Diego-based AristaMD , which is developing software tools to help coordinate referrals by physicians to specialists, has raised $11M in a Series A funding round. The funding was led by Avalon Ventures, and also included Correlation Ventures.

Avalon 100

Avalon San Diego Tool Research 100

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. AnapytsBio is venture backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures and Novo A/S. READ MORE>>.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. and $16.00

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

NOVEMBER 3, 2014

San Diego-based Proximal Data , a developer of storage caching software aimed at use with virtualized systems, has been acquired by Samsung Electronics , Samsung said today. Proximal Data was venture backed by Divergent Ventures and Avalon Ventures, and had only announced around $5M in funding.

Avalon 138

Avalon San Diego Software Acquisition 138

socalTECH

MARCH 21, 2014

San Diego-based Otonomy , a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps was previously EVP, CFO, and treasure for DJO Global, and also previously had served at Ernst & Young. READ MORE>>.

Avalon 138

Avalon San Diego Capital Develop 138

socalTECH

DECEMBER 4, 2015

San Diego-based Enlibrium announced Thursday that it has raised $15M in a Series A financing, to go towards cancer therapeutics. The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners.

UCLA 100

UCLA Avalon San Diego Los Angeles 100

socalTECH

APRIL 20, 2012

San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday.

Report 157

Report Avalon San Diego News 157

socalTECH

JUNE 9, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm.

Avalon 159

Avalon San Diego Venture Capital Capital 159